PGR and neoplasm: Our data revealed that the luminal tumor co-marker progesterone receptor (PR), which is linked to an immunosuppressive tumor microenvironment [55,56], displayed a decrease in expression at the highest significance as compared to the cold subgroup (Figure 4B,C).